Department of Cardiology, Toyohashi Heart Center, Aichi, Japan.
JACC Cardiovasc Interv. 2010 Feb;3(2):165-71. doi: 10.1016/j.jcin.2009.10.026.
The aim of this study was to report the initial experience with a novel catheter in the retrograde approach for chronic total occlusion (CTO).
Although the use of the retrograde approach in percutaneous coronary intervention for CTO has been established, some procedural difficulties remain.
A novel over-the-wire catheter (channel dilator) specifically designed for the retrograde approach has been developed for the treatment of CTO. The channel dilator was used in 93 CTO lesions after successful wiring of collateral channels using the retrograde approach.
Successful channel crossing of the catheter was achieved in 90 of the lesions (96.8%), and the channel dilator successfully advanced into the occlusion reversely during retrograde wiring in 85 lesions (94.4%). Of the 75 lesions with successful advancement of the retrograde wire into the proximal true lumen, the entire occlusion was crossed retrograde with the channel dilator in 63 lesions (84.0%). To evaluate the feasibility of the catheter, 93 CTO lesions in the preceding period were compared. Procedure and fluoroscopy time tended to be lower in the study group than in the control group. The success of the retrograde procedure was significantly higher in the study group than in the control group (98.9% vs. 92.5%, p = 0.030).
The channel dilator may facilitate the conventional retrograde approach with a high level of success.
本研究旨在报告一种新型导管在逆行技术治疗慢性完全闭塞(CTO)中的初步经验。
尽管逆行技术在 CTO 的经皮冠状动脉介入治疗中已经确立,但仍存在一些操作上的困难。
专门设计用于逆行技术的新型经导丝导管(通道扩张器)已被用于治疗 CTO。在成功使用逆行技术通过侧支通道进行布线后,在 93 例 CTO 病变中使用了通道扩张器。
90 例病变(96.8%)成功实现了导管的通道交叉,85 例病变(94.4%)在逆行布线过程中成功地将通道扩张器逆行推进到闭塞部位。在 75 例成功将逆行导丝推进到近端真腔的病变中,63 例病变(84.0%)成功地使用通道扩张器逆行穿过整个闭塞部位。为了评估导管的可行性,将 93 例 CTO 病变与前一时期进行了比较。研究组的手术和透视时间较对照组有降低的趋势。研究组的逆行手术成功率显著高于对照组(98.9%对 92.5%,p=0.030)。
通道扩张器可能会提高常规逆行技术的成功率。